Latanoprost Eg (Latanoprost)

Latanoprost acts as a prostaglandin F (FP) receptor agonist in the eye. Activation of these receptors remodels the extracellular matrix in the ciliary muscle, increasing uveoscleral outflow of aqueous humor and thereby reducing intra‑ocular pressure.

The dosing regimen for Latanoprost Eg is determined by the prescribing clinician. Typically, one drop is instilled in the affected eye(s) once daily, but the exact dose and timing should follow the prescriber’s instructions.

Latanoprost’s pregnancy category is listed as unknown. It should only be used during pregnancy or lactation if the potential benefit justifies the potential risk to the fetus or infant, and after consultation with a healthcare professional.

To order Latanoprost Eg, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

The primary alternative class for glaucoma includes beta‑blocker eye drops such as timolol. While beta‑blockers reduce aqueous humor production, Latanoprost increases uveoscleral outflow. Latanoprost often provides a once‑daily regimen with a different side‑effect profile, making it a preferred option for many patients.

Latanoprost should be stored at room temperature, below 25 °C, in its original container. Protect the bottle from light and moisture, and keep it out of reach of children. Do not freeze the solution.

Instill one drop of Latanoprost into the affected eye(s) once daily, preferably in the evening. Avoid touching the tip of the bottle to the eye or any surface, and wait at least 15 minutes before inserting contact lenses.

Serious risks include severe allergic reactions, uveitis (inflammation of the uveal tract), and macular edema, which can affect central vision. Patients should seek immediate medical attention if they experience sudden eye pain, vision loss, or signs of an allergic response.

Latanoprost should not be used by individuals with known hypersensitivity to the drug or any of its excipients, and it is contraindicated in eyes with active infections or inflammation. Caution is also advised for patients with corneal disease or a history of intra‑ocular inflammation.